Tel :
+33(0)5 55 05 69 83
Courriel :
secretariat.cic@chu-limoges.fr
Adresse
2 Av. Martin Luther King, Limoges
fr en
Research Development

Research Development

The CIC's research activities are structured around 4 main areas that combine clinical and fundamental research, with Infectious Diseases being the main focus.
See more
Training and teaching

Training and teaching

Training in clinical research, in partnership with the Faculties of Medicine and Pharmacy of Limoges.
See More
publis
Publication and dissemination of research
In collaboration with the teams linked to the CIC
See more
 

Objectives

To promote clinical research development related to the areas of excellence of the Limoges University Hospital (CIC), on a regional (ARCH) and European (Increase) scale

 
title line
 
Translational research
Translational research
To develop research activities at the crossing of the Inserm and CNRS-labelled units for fundamental research and clinical units of the University Hospital.
Support for research
Support for research
Logistical support for complex multi-centre therapeutic clinical trials and clinical epidemiological research (cohorts).
Scientific focus
Scientific focus
The CIC is associated with the 3 labelled research teams of the University Hospital and centred its development on the areas of Infectious Diseases, Pharmacology, Immunology and Haematology, and Ultrasounds, with a common focus on Sepsis.
Industrial partnerships
Industrial partnerships
These partnerships aim to bring together industry and academia in the development and transfer of new technologies that enhance biomedical research.
 
 

54

STUDIES SET UP IN 2024

278

ON GOING STUDIES

4227

PATIENTS INCLUDED IN 2024

30

TRAINED STUDENTS IN  2024

Latest News

14Nov
14Aug

Juillet 2025 : Démarrage du projet PLATINIUM

Return
14 Aug, 2025 — 14 Nov, 2025   
Event summary
Etude sélectionnée au PHRC National 2023, et financée en 2024
Event details

Cette étude de phase II portée par le Docteur B. François vise à démontrer le bénéfice d’une immunothérapie standardisée par Interféron gamma sur l’incidence des infections secondaires chez les patients hospitalisés en réanimation présentant une immunosuppression soutenue.

plus d'information sur le site : https://platinium-trial.fr/